Related Experiment Video
Updated: Aug 5, 2026
08:00
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
Published on: April 16, 2019
Refractory dissecting Cellulitis of the Scalp Successfully controlled with Adalimumab
Rafael F Martin-García1, Jennifer M Rullán2
1Board Certified Dermatologist, Program Director of the University of Puerto Rico, Associate Professor of the University of Puerto Rico.
Puerto Rico Health Sciences Journal
|June 11, 2015
Abstract:
Dissecting cellulitis of the scalp (DCS) is an uncommon inflammatory disease that often results in scarring alopecia. Numerous therapies have either proved ineffective or only temporarily effective in the management of this condition. Recent reports show adequate responses to tumor necrosis factor (TNF) inhibitors in cases of DCS. We report a case of severe recalcitrant DCS successfully treated with adalimumab.